Rebates And Discounts Have A Big Impact On US Drug Prices, IQVIA Report Shows

A new US drug spending report from IQVIA parses out how rebates impact drug spending and explores affordability for patients. The data show drug makers offset about 28% of drug spending and provide some support to industry's arguments on drug pricing.

Manufacturer discounts, rebates and other price concessions on brand drugs reduced US drug spending by about 28% to $324.4bn in 2017, according to a report from the IQVIA Institute for Human Data Science released April 19.

The report aims to parse out how rebates and discounts impact drug spending in the US and also explores drug...